Professor John Turnidge AO[/caption]
FIP President Paul Sinclair AM MPS (left)[/caption]
‘Health care across the world is changing very quickly. It’s being driven by innovation, and pharmacists historically have embraced innovation and technology,' he said.
‘What excites me most about our profession at the moment is that we have the chance to do more. Our scope of practice is expanding rapidly, and with that comes opportunities to help more people deliver more outcomes and improve the health system.'
[post_title] => What are pharmacists doing in other countries?
[post_excerpt] => Pharmacists present to the International Pharmaceutical Federation (FIP) on unique services in their country to improve health and safety.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => what-are-pharmacists-doing-in-other-countries
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-04 16:43:37
[post_modified_gmt] => 2024-09-04 06:43:37
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://www.australianpharmacist.com.au/?p=27474
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[title_attribute] => What are pharmacists doing in other countries?
[title] => What are pharmacists doing in other countries?
[href] => https://www.australianpharmacist.com.au/what-are-pharmacists-doing-in-other-countries/
[module_atts:td_module:private] => Array
(
)
[td_review:protected] => Array
(
)
[is_review:protected] =>
[post_thumb_id:protected] => 27493
[authorType] =>
)
This educational activity was managed by PSA at the request of and with funding from GSK.[/caption]
Understanding and awareness
Topline information for shingles and RSV
Critical factors for pharmacy-led vaccination [for more information please refer to the PSA's Practice Guidelines for the provision of immunisation services]28
Natasha Dean (she/her) 
Case scenario
Nia, 36 years old, presents to the pharmacy for advice, reporting difficulties falling asleep for the past 5 months. These problems started after a sporting injury. Although her injury has improved, Nia is still having difficulties sleeping. She reports that as soon as her head hits the pillow, she feels like her mind springs into action. You confirm that she isn’t on any medicines, has no medical conditions and works full-time in the retail industry with regular daytime hours.
References
- Ohayon M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6(2):97–111.
- Ohayon MM, Reynolds CF. Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med 2009;10(9):952–60.
- Appleton SL, Reynolds AC, Gill TK, et al. Insomnia prevalence varies with symptom criteria used with implications for epidemiological studies: role of anthropometrics, sleep habit, and comorbidities. Nat Sci Sleep 2022;14:775.
- Riemann D, Espie CA, Altena E, et al. The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023. J Sleep Res 2023;32(6):e14035.
- Royal Australian College of General Practitioners (RACGP). Prescribing drugs of dependence in general practice, Part B: Benzodiazepines. 2019.
- Australasian Sleep Association. Sleep Health Primary Care Resource: evidence-based resources and information to assess and manage adult patients with obstructive sleep apnoea and insomnia. 2021. At: www.sleepprimarycareresources.org.au/
- Ree M, Junge M, Cunnington D. Australasian Sleep Association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adults. Sleep Med 2017;36:S43–S7.
- Miller CB, Valenti L, Harrison CM, et al. Time trends in the family physician management of insomnia: the Australian experience (2000–2015). J Clin Sleep Med 2017;13(06):785–90.
- Haycock J, Lack L, Hoon E, et al. O048 Help seeking behaviours of Australian adults with insomnia in a community sample. Sleep DownUnder; Brisbane, Australia: Sleep Adv 2022:A20.
- Haycock J, Hoon E, Lack L, et al. Insomnia management in Australia: an overview of patient, clinician and health system factors. Sleep Adv 2023;4(Suppl 1):A12.
- Hauri P. Current concepts: the sleep disorders. Kalamazoo, MI: The Upjohn Company 1977;578:579.
- Chung KF, Lee C, Yeung W, et al. Sleep hygiene education as a treatment of insomnia: a systematic review and meta-analysis. Family Practice 2017;35(4):365–75.
- Sleep Health Foundation. Sleep hygiene: good sleep habits. 2024. At: www.sleephealthfoundation.org.au/sleep-topics/sleep-hygiene-good-sleep-habits
- Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J ClinSleep Med 2021;17(2):263–98.
- Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4(5).
- Winter S, Meaklim H, Kennedy G, et al. Sleep problems in psychological practice. InPsych 2022;44.
- Australian Government Department of Health and Aged Care. Better access initiative. At: www.health.gov.au/our-work/better-access-initiative
- Australasian Sleep Association. CBTi – Referral to digital CBTi programs. 2024. At: www.sleepprimarycareresources.org.au/insomnia/cbti/referral-to-digital-cbti-programs
- Sweetman A, Zwar N, Grivell N, et al. A step-by-step model for a brief behavioural treatment for insomnia in Australian General Practice. Aus J Gen Prac 2020;50(50):287–93.
- Germain A, Moul DE, Franzen PL, et al. Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med 2006;2(4):403–6.
- Sansom L, ed. Insomnia. Australian pharmaceutical formulary and handbook; Canberra; Pharmaceutical Society of Australia. 2024. At: https://apf.psa.org.au/treatment-guidelines-pharmacists/insomnia
- Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatry Clinics of North America 1987;10(4):541–53.
- Perlis M, Shaw PJ, Cano G, et al. Models of insomnia. Principles and practice of sleep medicines 2011;5(1):850–65.
- Fuller JM, Wong KK, Hoyos C, et al. Dispensing good sleep health behaviours not pills – a cluster‐randomized controlled trial to test the feasibility and efficacy of pharmacist‐provided brief behavioural treatment for insomnia. J Sleep Res 2016;25(1):104–15.
Our authors
Dr Alexander Sweetman (he/him) PhD
Alex is a Senior Program Manager, and chair of the psychologist education subcommittee at the Australasian Sleep Association. He is interested in and improving evidence-based management of sleep disorders and promoting access to cognitive behavioural therapy for insomnia.
Adjunct Clinical Associate Professor Moira Junge (she/her) DPsych (Health)
Moira is an Adjunct Clinical Associate Professor at Monash University and is a practicing Health Psychologist. She is the CEO of the Sleep Health Foundation. As a clinician, she has had a great deal of experience with treating sleep disorders and insomnia is her specialist area. She has been involved in several publications related to these topics.
Our reviewers
Morna Falkland BPharm
QUALITY USE OF MEDICINES FOR INSOMNIA AND SLEEP HEALTH (QUMISH) STEERING COMMITTEE
Conflicts of interest declarations
Dr Sweetman reports research equipment and/or funding support from the National Health and Medical Research Council, Medical Research Future Fund, Flinders University, the Flinders Foundation, the Hospital Research Foundation, Big Health, Philips Respironics, Compumedics, ResMed, and commissioned/consultancy work for Australian Doctor, Sleep Review Mag, Re-Time Australia, American Academy of Dental Sleep Medicine, the Australian and New Zealand Academy of Orofacial Pain, ResMed, and Cerebra.
Moira Junge is on the health advisory board of healthylife, which is owned by Woolworths and is CEO of the Sleep Health Foundation.
